Concepedia

E. Rivera

ER

Statistics

Publications

4

Citations

166

H-Index

4

Active since

1997

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

E. Rivera is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, cancer pharmacology, and chemotherapy.

ORCID

Publications per year

1997–2011

4

Publications

4

Maximum-tolerated dose defined for single-agent gemcitabine: a phase I dose-escalation study in chemotherapy-naive patients with advanced non-small-cell lung cancer.

Frank V. Fossella, S. M. Lippman, Dong M. Shin et al. · Journal of Clinical Oncology · 1997 · 130 citations

, , +15

Liposomal Anthracyclines in Metastatic Breast Cancer: Clinical Update

E. Rivera · The Oncologist · 2003 · 13 citations · Full text

, , +17

Phase I combination study of trabectedin and capecitabine in patients with advanced malignancies

Lia Gore, E. Rivera, M. Basche et al. · Investigational New Drugs · 2011 · 12 citations

, , +9

Goserelin plus anastrozole in the treatment of premenopausal hormone receptor positive, recurrent or metastatic breast cancer

R. W. Carlson, Christine M. Schurman, E. Rivera et al. · Journal of Clinical Oncology · 2007 · 11 citations

, , +17

1–4 of 4